CONFIRMED: Tanzania’s first-line malaria drug remains effective
A recent study conducted in Tanzania in 2022 has confirmed that the malaria drug known as artemether-lumefantrine (AL), the country’s first-l…
A recent study conducted in Tanzania in 2022 has confirmed that the malaria drug known as artemether-lumefantrine (AL), the country’s first-l…
Tanzania was represented at the 2024 Global Evid…
The Ifakara Health Institute’s Director of…
The Ifakara Health Institute Chief Executive, Dr. Honorati Masanja, engaged…
In an article published by Global Times on Se…
A new clinical trial is underway in Tanzania, seeking to address the mental health challenges faced by young people living with HIV (YPLWH). The tr…
Farida Katunzi, a Research Scientist at Ifakara Health Institute, highlight…
Indoor Residual Spraying (IRS) has long been a key method for controlling malaria control. The method involves spraying all accessible surfaces in …
"MTAFITI" - the monthly news and event…
On the World Mosquito Day, August 20, 2024, Dr. …